Biopharma News : Biopharma and Pharma news from all around the world :
- GE HealthCare builds on a century of innovation to shape the future of radiology at RSNA 2025
- GE HealthCare unveils next-generation SIGNA MRI technology, aiming to boost efficiency, enhance patient experience, and advance sustainability
- Fifty Countries Strong: AHF ‘Keeping the Promise’ on World AIDS Day
- CAR T-Cell Therapy for the Multiple Myeloma Market, 2025-2035: Extensive Data on Products, End Users, Regions and Companies – ResearchAndMarkets.com
- Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference
- U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
- Corstasis Therapeutics and Cardiovascular Logistics Partner to Redefine Outpatient Heart Failure Care with ENBUMYST™ (Bumetanide Nasal Spray)
- With Two in Five Employees Undergoing Fertility Treatment Leaving Their Jobs or Considering Quitting, Are Companies Doing Enough?
- Otsuka Receives FDA Accelerated Approval for VOYXACT® (sibeprenlimab-szsi) for the Reduction of Proteinuria in Adults with Primary Immunoglobulin A Nephropathy (IgAN) at Risk for Disease Progression
- Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
- Arrowhead Pharmaceuticals Reports 2025 Fiscal Year-End Results
- Alkermes to Participate in Two Upcoming Investor Conferences
- Jay & Raman Bhaumik Announce Thesis Pharmacy Rebranding from Texas Star, Signaling Precision Growth and National Expansion
- Piroxicam (CAS 36322-90-4) Industry Research Report 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 – Applications, Pricing, Manufacturers, End-Users, and Downstream Trends – ResearchAndMarkets.com
- Pentazocine (CAS 359-83-1) Industry Research Report 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 – Applications, Pricing, Manufacturers, End-Users, and Downstream Trends – ResearchAndMarkets.com
- Merck Data to be Presented at ASH 2025 Annual Meeting Showcase Continued Advancements in Hematology Pipeline and Novel Therapeutic Approaches
- BioCorteX Announces Strategic Partnership with CD Biopharma of China
- POXEL SA: Update on the Proposed Recovery Plan and Organisation of a Webinar
- Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention
- Owkin Unveils Europe’s First Pan-European Agentic Infrastructure for Biology at the Franco-German Digital Sovereignty Summit
- SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
- Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers
- Arrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
- Lifordi Immunotherapeutics Secures Strategic Investment from Sanofi Ventures and Additional Capital from Existing Investors
- CELFULL Showcases Aging Intervention Technology at SupplySide Global to Lead New Trends 2026
- Sofinnova Partners Closes €650M ($750M) Capital XI, Greatly Exceeding Initial Target to Back Early-Stage Healthcare Deals
- HSS Researchers Report Benefits of Robotic-Assisted Spine Surgery for Adolescent Athletes with Back Pain Due to Pars Fractures
- Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.
- Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results
- Merck to Participate in the Jefferies Global Healthcare Conference in London
News about Biotech, Pharma, Biopharma, Medical Devices, Diagnostics, Digital Health
- Viromed Medical AG and HELLMUT RUCK GmbH have concluded an exclusive distribution agreement for plasma devices
- Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process Following U.S. Government Shutdown
- Asklepios Group: Solid third quarter of 2025 – successful placement of Social Schuldschein loan strengthens financing basis
- Viromed confirms talks with an international MedTech company regarding a cooperation in the field of wound care
- Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
- CureVac Announces Voting Results of Extraordinary General Meeting
- Straumann Group outlines its mid-term growth strategy to accelerate market shares, strengthen profitability and increase cash generation
- Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination
- Heidelberg Pharma Announces Changes to the Executive Management Board – Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer
- CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates
- NTC becomes commercialization partner for Formycon’s Eylea® biosimilar FYB203/Baiama® in Italy
- Medartis appoints Peter Hackel as new Chief Financial Officer
- Sandoz launches Afqlir® (aflibercept) in Europe, providing affordable treatment option for patients with retinal diseases
- Uni-Bio Science Group Embarks on New Strategy and Launches New Website, Advancing Towards Becoming a Global Leader in Regenerative Medicine
- Bayer Aktiengesellschaft: Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention
- Curatis Holding AG announces CHF 1.2 million private placement with strategic investor
- FamiCord AG accelerates profitable growth in the third quarter of 2025 and further strengthens quality and visibility of revenues
- Gerresheimer AG: Change in the Supervisory Board
- MPH Health Care AG publishes figures for the third quarter of 2025: Equity (NAV) amounts to EUR 194.2 million, corresponding to EUR 45.36 per share. The equity ratio fell slightly to 92.8%
- Ranibizumab Biosimilar Epruvy® launched in Germany
- SYNBIOTIC strengthens its presence at international events and monitors advances in cannabis research
- Gerresheimer: Science Based Targets Initiative confirms CO2e Reduction Targets
- M1 Kliniken AG reports strong EBIT Growth of 11% and achieves Earnings per Share of EUR 0.86.
- Formycon achieves key development milestone with FYB208: Biosimilar candidate for Dupixent® (dupilumab) adds another growth driver to the biosimilar portfolio
- Siegfried announces Chief Financial Officer transition
- Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX
- Grünenthal announces pricing of bond extension
- DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026
- Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
- Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision
- Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform
- At RSNA 2025, ASCEND Cardiovascular and Konica Minolta Healthcare Announce Partnership to Deliver a Best-in-Class Enterprise Imaging Solution that Elevates Cardiovascular Care
- Konica Minolta Healthcare Launches New Floor-Mounted Digital Radiography Systems at RSNA 2025
- DeepHealth Unveils Next-Generation Imaging Informatics and Clinical AI Solutions at RSNA 2025, Advancing a New Standard of AI-Powered Care
- Anabolic Steroids Alternatives: Muscle Building Supplements from CrazyBulk | Most Selling Muscular Endurance Supplements Bodybuilders Use For Peak Performance & Strength Building in 2025
- Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program
- Algernon Closes Second Tranche of Private Placement Financing
- INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”
- Pasithea Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
- NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update
- PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference
- Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Hydreight Technologies Acquires 5% Equity Stake in Perfect Scripts, LLC, with Option to Increase up to 40%, and Establishes Strategic Partnership
- Boehringer Ingelheim announces appointment to Board of Managing Directors
- Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
- TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
- Results of the Votes of the Combined Shareholders’ General Meeting of November 27, 2025
- Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer
- InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis
- Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer’s Disease in Japan
- Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer’s Disease in Japan
- HealthTab™ to Power NHS Pilot
- HealthTab™ to Power NHS Pilot
- Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
- Dipharma publishes a peer-reviewed study in Organic Process Research & Development: a novel approach to detect and characterize nitrosamine formation in APIs
- Dipharma publishes a peer-reviewed study in Organic Process Research & Development: a novel approach to detect and characterize nitrosamine formation in APIs
- GENFIT Announces Appointment of new Chief Medical Officer
- Freya Pharma Solutions Rebrands as Arletta Pharma Solutions, Marking New Phase in Women’s Healthcare Innovation
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites for more info.
Biopharma News – Pharma News